OSMR产品信息
英文名称:Oncostatin-M-specific receptor subunit beta
中文名称:抑瘤素-M-特异性受体β亚基
靶点别称:OSMR,IL-31RB,Interleukin-31 receptor subunit beta
物种:Human/Cynomolgus/Canine
属性:Protein
标记:Unconjugated
内毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
纯度(Purity)
>95% as determined by SDS-PAGE.
制剂(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重构方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存储(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
![1.jpg 1.jpg](/SupplyImg/2024-04-28/6384991665221792168730154.jpg)
OSMR分子背景
Oncostatin-M特异性受体亚基β(OSMRB)也称为白细胞介素-31受体亚基α(IL-31RB),是OSM受体复合物(gp130和OSMRβ的异二聚体)的替代亚基(OSMRβ),由OSM激活,但不由LIF激活。OSMRβ与低亲和力OSM·gp130复合物结合形成高亲和力异二聚体受体,能够转导OSM特异性信号事件。
![通用.jpg 通用.jpg](/SupplyImg/2024-04-28/6384991665855791997896648.jpg)
关键字: OSMR;OSMR蛋白;OSMR重组蛋白;ACRO;百普赛斯;
百普赛斯集团ACROBiosystems Group(股票代码:301080)是成立于2010年的跨国生物科技公司,是为全球生物医药、健康产业领域提供关键生物试剂产品及解决方案的行业平台型基石企业。2021年在创业板上市。百普赛斯集团业务遍布全球,横跨亚洲、北美洲、欧洲,在中国、美国、瑞士等12个城市设有办公室、研发中心及生产基地。目前累计服务客户超6000家,与全球Top 20医药企业均建立了长期、稳定的合作伙伴关系。集团旗下拥有品牌ACROBiosystems百普赛斯、bioSeedin柏思荟、Condense Capital垦拓资本和ACRODiagnostics百斯医学等。